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Background: Relationships among clinical, physiological, imaging and pathological findings of
small airway disease associated with Sjo¨gren’s syndrome have remained unclear.
Subjects and methods: We retrospectively studied 14 patients who underwent surgical lung
biopsy and who were diagnosed with small airway disease associated with primary or
secondary Sjo¨gren’s syndrome. We compared clinical, bronchoalveolar lavage, physiological,
imaging and pathological findings between primary and secondary Sjo¨gren’s syndrome. We
scored HRCT and pathological abnormalities and investigated correlations among physiolog-
ical, HRCT and pathological data, changes in physiological parameters and in HRCT scores
after two years of treatment, as well as correlations between these values and pathological
scores.
Results: Bronchoalveolar lavage fluid, physiological, imaging and pathological findings of the
airways did not significantly differ between primary and secondary Sjo¨gren’s syndrome. Air
trapping on HRCT negatively correlated with MEF50 and MEF25. Although lymphoid cell infil-
tration and peribronchiolar fibrosis were the most common pathologies, constrictive change
scores correlated negatively with MEF50 and MEF25, positively with air trapping scores and
negatively with improvements after therapy in MEF50, MEF25 and air trapping.of Respiratory Medicine, Shinseikai Toyama Hospital, 89-10 Shimowaka, Imizu City, Toyama 939-0243,
1 766 52 2197.
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1932 M. Nakanishi et al.Conclusions: Constrictive change was the most significant determinant of physiological and
imaging presentations and of changes in these factors after therapy for small airway disease
associated with Sjo¨gren’s syndrome.
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Sjo¨gren’s syndrome (SjS) is an inflammatory connective
tissue disorder of unknown etiology, characterized as an
autoimmune exocrinopathy.1 Various types of pulmonary
involvement are associated with SjS, including interstitial
pneumonia, lymphoproliferative disorders2,3,4,5,6 and small
airway disease.2,3,7
Sjo¨gren’s syndrome is often associated with other
connective tissue disorders (CTDs), especially rheumatoid
arthritis (RA). Such conditions are referred to as secondary
SjS (sSjS), whereas SjS without other CTDs is termed
primary SjS (pSjS).8 Small airway disease is a frequent
feature of many patients with RA and constrictive or
follicular types of bronchiolitis are considered representa-
tive of the pathologies associated with RA.9,10,11,12,13,14,15
However, the histopathological features of a case series
of small airway disease associated with SjS have never been
studied and differences in small airway disease between
pSjS and sSjS remain unclear.
Air trapping on high-resolution CT (HRCT) is a sensitive
method of detecting the early features of small airway
disease.16 However, the relationship between air-trapping
and histopathological abnormalities in small airway
disease associated with SjS has not been investigated. In
addition, although corticosteroid is effective for treating
bronchiolitis in adults with other etiologies,17 changes in
physiological impairment or in HRCT abnormalities after
therapy and the relationships between these changes and
pathological abnormalities in small airway disease associ-
ated with SjS have not been examined.
We retrospectively investigated various clinical aspects
and histopathological findings of small airway disease
associated with SjS proven by surgical lung biopsy (SLB), as
well as differences in these findings between pSjS and sSjS.
We also assessed whether pulmonary function test (PFT)
and HRCT findings in small airway disease associated with
SjS accurately reflect histopathological findings. We also
examined relationships among histopathological findings,
changes in pulmonary function and HRCT abnormalities.
Methods
Study design and patients
We retrospectively studied 14 patients who underwent
surgical lung biopsy (SLB) and who were diagnosed with
small airway disease associated with SjS between April 1999
and March 2005. Eight of them presented at our institutions
with continuous respiratory symptoms and six were
referred to us for detailed investigations of respiratory
conditions from other institutions. None of the 14 patients
had been previously diagnosed with SjS. Three patients hadbeen diagnosed with RA at the time of presentation. All 14
were diagnosed with SjS and two patients were diagnosed
as having SjS associated with RA within one month after
presentation at our institution. No other connective tissue
disorders (CTDs) were recognized during observation
periods of over 24 months (45  16 months; mean  SD). All
patients fulfilled the 2002 revised criteria for SjS defined by
the European Study Group on Classification Criteria for
Sjo¨gren’s syndrome.18 Three patients without sicca symp-
toms were positive for at least three of the four objective
criteria including histopathology of minor salivary glands.
We excluded patients with findings of interstitial pneu-
monia or emphysema defined by HRCT, and those with
lymphoma, diffuse panbronchiolitis and respiratory bron-
chiolitis associated with interstitial lung disease. None of
the patients had received prior gold or penicillamine
therapy. All of the 14 patients underwent PFT, fiberoptic
bronchoscopy and HRCT one to three weeks before surgical
lung biopsy. Demographic data, clinical presentation,
physical findings and laboratory results were extracted
from the medical records. All patients provided written,
informed consent to participate in the study, which was
approved by the internal review boards of our institutions.
All patients were treated and underwent annual PFT and
HRCT examinations for over two years at our institutions.
We analyzed HRCT abnormalities at the time of diagnosis
and at two years thereafter, as well as histopathological
findings of biopsy specimens. We compared initial clinical
presentations, physical, laboratory, bronchoalveolar lavage
fluid (BALF) findings and histopathological scores between
patients with pSjS and sSjS. We also compared PFT results
and HRCT scores at diagnosis and at two years later
between patients with pSjS and sSjS.
Pulmonary function tests
The PFT data included forced vital capacity (FVC), forced
expiratory volume in 1 s (FEV1)/FVC, residual volume (RV)/
total lung capacity (TLC), diffusion capacity for carbon
monoxide (DLco) and maximum expiratory flow at 25 and
50% (MEF25 and MEF50). Observed values were compared
with those predicted for the age, gender and height of each
individual. The PFT results are expressed as a percentage of
predicted values.
Scoring HRCT abnormalities
We scored the following findings from CT scans obtained at
suspended end-inspiratory volumes: centrilobular nodules,
branching linear opacity, bronchial wall thickening, bron-
chial dilation and interlobular septal thickening, and scored
air trapping at end-expiratory volumes. Individual abnor-
malities on each HRCT slice were graded as 0, absent; 1,
1%e25% of the cross-sectional area of the lung affected; 2,
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affected. The extent of low attenuated areas was esti-
mated to score air trapping as described.16 Scores for each
patient were calculated by averaging the values in all CT
slices. We simply determined the presence or absence of
large nodules (7 mm) and cysts.
Histopathological findings and scores
Histopathological findings were investigated and scored by
pulmonary pathologists (JF and TT) who were blinded to
the clinical, physiological and HRCT findings. Findings in
small airways alone were scored. Membranous (MB) and
respiratory (RB) bronchioles were individually assessed. The
individual features scored in MB comprised (a) peri-
bronchiolar fibrosis, (b) mucous plugs, (c) lymphoid cell
infiltration, (d) basement membrane thickening, (e)
constrictive change, (f) luminal macrophages, (g) dilation,
(h) eosinophils, (i) goblet cell hyperplasia and (j) neutro-
phils. Findings scored in RB comprised (a) peribronchiolar
metaplasia, (b) peribronchiolar fibrosis, (c) mucous plugs,
(d) lymphoid cell infiltration, (e) constrictive change, (f)
airspace macrophages, (RB macrophages), (g) eosinophils.
Each finding was graded as 0, none; 1, weak; 2, moderate
and 3, marked as described.19 The numbers of MB and RB
were counted for each patient. The pathological scores for
each finding were calculated as follows: the grade and
number of observed bronchioles in each grade were firstly
multiplied, and then the sum of all multiplied numbers in
each finding was divided by the total number of bronchioles
identified in the specimen. Here, pathological scores  1.0
were considered abnormal. Histopathological diagnoses
were defined as follows. Follicular bronchiolitis comprised
hyperplasia of bronchus-associated lymphoid tissue so that
airways have prominent lymphoid tissue with follicles and
a germinal center. Constrictive bronchiolitis was defined as
bronchiolar lumens that were narrowed or obliterated by
submucosal fibrous tissue. Non-specific chronic bronchioli-
tis was defined as bronchioles with infiltrating chronic
inflammatory cells that did not conform to any specific
histopathological diagnosis.
We investigated correlations among pathological scores,
between initial PFT results and initial HRCT scores,
between pathological scores and initial PFT results and
between pathological scores and initial HRCT scores.
Correlations between pathological scores and changes in
PFT results and changes in HRCT after treatments.
We summarized treatment strategies for all of the
patients, and investigated the relationship between treat-
ment and subjective/objective improvement over a period
of two years. We compared PFT results and HRCT scores for
all patients at the time of diagnosis and at two years later.
We calculated differences between PFT results and HRCT
scores at the time of diagnosis and those at two years later.
We also investigated correlations between pathological
scores and changes in PFT results and changes in HRCT.
Statistical analysis
Clinical, physiological, BALF, HRCT and histopathological
data were compared between patients with pSjS and sSjSusing Student’s t test or the c2 test. The PFT results and
HRCT scores at the time of diagnosis and at two years later
were compared using a paired t test. Relationships between
treatment strategies and subjective/objective improve-
ments were investigated using the c2 test. Relationships
among PFT results, HRCT and pathological scores, as well as
correlations between pathological scores and improve-
ments in physiological data as well as HRCT scores were
investigated using Pearson’s correlation coefficient.Results
Fourteen (11 females, three males) of the patients included
in this study were aged 55.8  14.3 (mean  SD; range
27e76) years. In total, 7 (50%) had never smoked and five
had previously smoked and quit. All patients had cough, 5
(36%) had sputum, 7 (50%) had dyspnea on exertion and 5
(36%) had fever. Arthralgia and sicca symptoms were found
in six and 11 patients, respectively. The mean interval
between respiratory symptoms and SLB was 12  25 (range
3e60) months. The mean interval between sicca symptoms
and SLB was 7  29 (range 0e69) months.
Table 1 summarizes the characteristics of patients with
pSjS (n Z 9) and with sSjS (n Z 5). Other than symptoms
and serological data associated with RA, respiratory symp-
toms, chest physical findings and laboratory results did not
significantly differ between the two groups. The total cell
count in BALF was increased in both groups. The numbers of
lymphocytes or neutrophils or both in BALF increased in
most patients, and BALF findings did not significantly differ
between the two groups. Respiratory infections were
caused by H. influenzae in one patient each with pSjS and
with sSjS, and by Pseudomonas in one patient each with
pSjS and sSjS.
The initial PFT results did not significantly differ
between the two groups (data not shown). The RV/TLC was
increased, whereas MEF50 and MEF25 were decreased in all
patients. The FEV1/FVC ratio was <70% in 3 of 9 and in 2 of
5 patients with pSjS and sSjS, respectively. The initial HRCT
scores also did not significantly differ between the two
groups (data not shown). Centrilobular nodules, bronchial
wall thickening and air trapping were evident in all
patients. Because cysts and large nodules were only found
in two and three patients, respectively, these features
were not scored. Air trapping scores significantly correlated
with RV/TLC (r Z 0.72, p < 0.01), MEF50 (r Z 0.56,
p < 0.05) and MEF25 (r Z 0.61, p < 0.05). No other
significant correlations were identified between PFT results
and HRCT scores. The PFT results and HRCT scores at two
years after diagnosis also did not significantly differ
between the two groups.
Table 2 summarizes the histological diagnosis and
abnormal histological findings. The histological diagnosis
was based on the most predominant histological finding in
the biopsy specimen from each patient. The most common
basis for a histological diagnosis of small airway disease was
non-specific chronic bronchiolitis, (n Z 9) followed by
follicular and constrictive bronchiolitis (n Z 2), follicular
(nZ 2), and constrictive (nZ 1) bronchiolitis. The amounts
of follicular and constrictive bronchiolitis were equal in two
of the five patients with sSjS, and histologically confirmed
Table 1 Comparison of patients’ characteristics, symptoms, laboratory data and BALF findings between pSjS and sSjS at the
time of diagnosis.
pSjS (n Z 9) sSjS (n Z 5) p value
Age (y) 57.8  11.0 52.6  18.2 0.58
Female gender 7 4 0.92
Current or former smoker 4 3 0.67
Cough 9 5
Sputum 3 2 0.80
Dyspnea on exertion 5 2 0.58
Fever 3 2 0.80
Arthralgia 1 5 0.001
Sicca symptoms 7 4 0.92
Wheeze 2 2 0.48
Sinusitis 4 3 0.57
Repeated respiratory infection 3 2 0.80
PaO2 (mmHg) 81.6  8.0 82.6  7.0 0.21
White blood cell count (/mL) 5803  2700 7138  3195 0.42
C-reactive protein (mg/dL) 1.95  1.36 2.71  3.08 0.53
RAPA positive 3 5 0.004
Antinuclear antibody positive 3 2 0.80
Anti-Ro antibody positive 5 2 0.58
Anti-La antibody positive 3 2 0.80
Bronchoalveolar lavage fluid findings
Total cell count (103/mL) 5.99  7.47 6.98  6.13 0.80
Macrophages (%) 51.0  22.7 38.6  25.4 0.38
Lymphocytes (%) 26.9  14.2 24.0  19.1 0.76
Neutrophils (%) 20.0  31.3 37.8  40.1 0.38
Eosinophils (%) 2.10  2.23 0.6  0.89 0.18
CD4/8 2.16  0.87 1.38  0.71 0.12
Positive bacterial cultures 2 2 0.48
Data are presented as numbers, or as means  standard deviation.
PaO2, arterial oxygen tension; RAPA, rheumatoid arthritis particle agglutination.
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which comprised foci of mild organizing pneumonia and the
other was focal and mild cellular interstitial pneumonia.
Findings in both of these patients were microscopically
detectable and these patients were included in the anal-
ysis. Among the 14 patients, 13 had MB and all 14 had RB in
specimens. The most frequent abnormal pathological find-
ings were lymphoid cell infiltration and peribronchiolar
fibrosis in both MB and RB. Histological abnormalities found
outside small airways comprised intimal fibrosis indicating
vessel wall thickening and these findings were limited to
those with secondary SjS.
Pathological scores for each finding in small airways did
not significantly differ between patients with pSjS and sSjS
(data not shown). The peribronchiolar fibrosis score signif-
icantly correlated with scores for lymphoid cell infiltration
(r Z 0.74, p < 0.05) and constrictive change (r Z 0.82,
p < 0.001) in MB. Lymphoid cell infiltration scores signifi-
cantly correlated with those of constrictive change in MB
(r Z 0.59, p < 0.05). No other pathological scores signifi-
cantly correlated. Constrictive change in MB correlated
negatively with MEF50 (r Z 0.77, p < 0.01) and MEF25
(r Z 0.74, p < 0.01), and positively with RV/TLC
(r Z 0.59, p < 0.05) and air trapping scores (r Z 0.67,
p < 0.01) (Figs. 1 and 2). Other pathological scores did notsignificantly correlate with either PFT results or HRCT
scores.
Cough and sputum improved after treatment in 12 of 14
and in 3 of 5 patients, respectively. However, dyspnea on
exertion improved in only 2 of 7 patients. Treatment was
individually tailored for all patients and none of them died.
Clarithromycin, inhaled corticosteroid and oral predniso-
lone (0.5e1 mg/kg) were administered to 11, 10 and 5
patients, respectively. Three patients with RA received
methotrexate. No other immunosuppressive agents were
administered. Treatment did not significantly correlate
with subjective or objective improvements in symptoms.
The patients were followed up using PFT and HRCT
between 23 and 25 months after diagnosis. None of the PFT
results or HRCT scores had significantly changed. The MEF50,
MEF25 andair trapping scores onHRCT tended to improve, but
the differencedid not reach significance (Table 3). TheMEF50
and MEF25 scores increased and decreased in seven patients
each. Air trapping scores improved and deteriorated in nine
and five patients, respectively (Fig. 3). Constrictive change
scores in MB negatively correlated with increased MEF50
(rZ0.67, p< 0.05), increased MEF25 (rZ0.69, p< 0.01)
and decreased air trapping scores on HRCT (r Z 0.57,
p < 0.05). No other changes significantly correlated with
pathological scores.
Table 2 Comparison of histopathological findings between pSjS and sSjS.
pSjS (n Z 9) sSjS (n Z 5) p
Histological diagnosis of small airway disease
Follicular bronchiolitis 1 3c 0.09
Constrictive bronchiolitis 1 2c 0.27
Non-specific chronic bronchiolitis 7 2 0.20
Histological findings (non airway)
Diffuse lymphoid hyperplasia 2 0 0.40
Pleural thickeningb 6 3 0.80
Vessel wall thickening 0 4 0.005
Emphysemab 3 3 0.34
Interstitial changeb 1 1 0.60
Findings in Small Airway
Membranous bronchioles (MB) n Z 9 n Z 4a
Peribronchiolar fibrosis 3 1 0.55
Mucous plug 1 1 0.60
Lymphoid cell infiltration 4 4 0.44
Basement membrane thickening 1 0 0.64
Constrictive change 1 2 0.27
Luminal macrophages 0 0
Dilation 1 0 0.64
Tissue eosinophilia 2 1 0.73
Goblet cell hyperplasia 1 0 0.64
Neutrophils 1 0 0.64
Respiratory bronchioles (RB) n Z 9 n Z 5
Peribronchiolar metaplasia 2 1 0.73
Peribronchiolar fibrosis 2 3 0.20
Mucous plug 0 1 0.36
Lymphoid cell infiltration 4 2 0.66
Constrictive change 0 1 0.36
RB macrophages 2 1 0.73
Tissue eosinophilia 0 0
a Specimen from only one patient with sSjS did not contain MB.
b Detectable only by microscopy.
c Amounts of follicular and constrictive bronchiolitis were equal in 2 of 5 patients with sSjS and histological assessment confirmed that
each had both types of bronchiolitis.
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Among the various features of small airway pathology
associated with SjS, lymphoid cell infiltration and peri-
bronchiolar fibrosis were the most predominant findings.
Scores for air trapping and physiological impairments in
small airways significantly correlated only with constrictive
changes among the various pathological findings. Further-
more, improvements in MEF50, MEF25 and air trapping scores
after treatment inversely correlated with scores for
constrictive change. These data showed that pathological
constrictive change is accurately reflected by small airway
abnormalities in PFT and HRCT and that although less
conspicuous, it is the most significant pathological deter-
minant of clinical presentations including response to
treatment.
To distinguish whether lung involvement is caused by SjS
or by other CTD components is difficult in patients with sSjS
accompanied by other CTDs. Our data indicated that none
of respiratory symptoms, BALF findings, PFT results, HRCT
abnormalities and small airway pathology significantlydiffers between pSjS and sSjS. However, this could be due
to the small patient cohort investigated herein. Pathologies
such as follicular, constrictive and lymphocytic bronchiolitis
are reportedly associated with SjS.12,13,15,20 However, the
present findings indicated that most of the small airway
disease associated with pSjS is non-specific chronic bron-
chiolitis and that follicular or constrictive bronchiolitis is
also an occasional feature of pSjS. On the other hand,
follicular bronchiolitis and constrictive bronchiolitis were
frequent features of sSjS associated with RA. The notable
finding that vessel walls were thickened only among
patients with sSjS in our cohort could be a specific feature
of RA.
Pathologies identified by HRCT in patients with SjS
include interstitial lung diseases, lymphoproliferative
disorders and small airway disease alone or in various
combinations.21,22,23,24 Although slight interstitial changes
were detectable in two of 14 patients by microscopy, the
HRCT findings in these patients reflected small airway
disease alone and were essentially similar to those of small
airway disease with other etiologies.9,10,14,25 Therefore,
small airway disease comprised the fundamental lung
Figure 1 Pathological correlation with HRCT findings in a 64-
year-old female patient with small airway disease associated
with primary Sjo¨gren’s syndrome. a) Histopathological findings
show mildly narrowed bronchiolar lumen as submucosal
fibrosis. Constrictive change of MB was judged as grade 2. b)
High-resolution CT at suspended end-inspiratory volumes shows
heterogeneous lung attenuation and centrilobular nodules. c)
High-resolution CT at end-expiratory volumes shows air-
trapping, centrilobular nodules and clearer extent of abnor-
mality. Air-trapping score was judged as grade 3.
Figure 2 Pathological correlation with HRCT findings in a 46-
year-old female patient with small airway disease associated
with secondary Sjo¨gren’s syndrome. a) Histopathological find-
ings show bronchiolar lumen severely narrowed by dense
collagenous fibrosis and moderate lymphocytic infiltration.
Constrictive change in MB was judged as grade 3 (EVG staining).
b) High-resolution CT at suspended end-inspiratory volumes
shows diffuse air-trapping and centrilobular nodules. c) High-
resolution CT at end-expiratory volumes shows diffuse air-
trapping and centrilobular nodules. Normal increase in atten-
uation and volume reduction were not evident in high-
resolution CT even at end-expiratory volumes. Air-trapping
score was judged as grade 4.
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characteristic of SjS, are found only in a small proportion of
patients.22,23,24
This study found a significant correlation between air-
trapping on HRCT and small airway obstruction determined
by PFT in small airway disease associated with SjS, although
others have found a poor correlation between physiological
data and air trapping on HRCT in such patients.26,27
However, these studies included patients with interstitial
pneumonia (including reticular opacities, ground glass
opacities and honeycombing on HRCT, small airway disease
and both).
Because scores for lymphoid cell infiltration, peri-
bronchiolar fibrosis and constrictive change significantly
correlated, these pathologies could worsen with disease
progression. Our results differed from those of a study that
found an inverse correlation between inflammation and
fibrosis and no correlation between the degree of bronchial
fibrosis and airflow limitation.28 This can be explained by
the fact that obliterative bronchiolitis in the patientsenrolled in that study was caused by various etiologies and
SjS was not included.
The optimal therapy for patients with small airway
disease associated with SjS remains unclear. Although
physiological parameters of small airway or air trapping on
HRCT after treatment did not significantly improve in our
patients, over half of them experienced some improve-
ments in symptoms. Because patients with SjS have
increased bronchial responsiveness,29 inhaled corticoste-
roid could be effective against small airway disease with
SjS. Erythromycin might be useful for patients with small
airway disease associated with RA or pSjS.10,30 In addition,
patients with small airway disease accompanied by SjS
might be predisposed to upper and lower airway infection,
and sinusitis or repeated respiratory infection has been
identified in patients with SjS.30,31 Such conditions could
modulate bronchiolar lesions in SjS and thus treating
infection would be important.
Table 3 Comparison of pulmonary function test results and HRCT scores between at diagnosis and at two years later.
Diagnosis Two years later P
Pulmonary function tests
VC (%pred) 96.8  12.2 95.3  11.2 0.13
FEV1/FVC (%pred) 74.6  8.5 76.2  8.9 0.12
RV/TLC (%pred) 41.3  7.5 39.7  8.4 0.09
DLco (%pred) 79.4  17.3 79.0  15.2 0.75
MEF50 (%pred) 37.3  11.5 39.6  13.9 0.08
MEF25 (%pred) 21.1  6.1 23.1  8.3 0.06
HRCT scores
Centrilobular nodules 1.57  0.5 1.43  0.5 0.33
Branching linear opacities 0.57  0.51 0.41  0.5 0.12
Bronchial wall thickening 1.29  0.47 1.07  0.61 0.08
Bronchial dilatation 0.5  0.8 0.57  0.85 0.33
Interlobular septal thickening 0.64  0.49 0.71  0.61 0.58
Air trapping 1.84  0.63 1.67  0.85 0.09
Data are presented as means  standard deviation.
Figure 3 Changes in MEF50 (a) and in air trapping scores on HRCT (b) after two years of treatment.
Small airway disease in Sjo¨gren’s syndrome 1937None of these 14 patients had been previously diagnosed
with SjS and therefore SjS was detected as a result of
respiratory involvement and a chief complaint of respira-
tory symptoms. This might mean that respiratory symptoms
comprise the first clinical presentation of SjS and that small
airway disease associated with SjS is one of several condi-
tions associated with respiratory symptoms such as chronic
cough.
The main limitation of this study is the inherent bias
associated with the small cohort of retrospectively studied
patients, although surgical lung biopsies were obtained from
all of them. This study could not determine the most
appropriate therapy because the corresponding clinicians
applied various treatment strategies. The relatively well-
preservedpulmonary function in this cohort of patients could
have potential implications on these results; for example,
significant improvement with therapy could be obscured.
Constrictive change is considered to be the most signif-
icant determinant for clinical presentation and a treatment
response in small airway disease associated with SjS. This
study indicated that disease progression is associated with
the progression of constrictive changes in the bronchioles
and less effective or ineffective treatment. Early diagnosis
and treatment is significant for small airway disease asso-
ciated with SjS, and appropriate treatment should be
further investigated.Conflict of interest
None.
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